Matrix metalloproteinases 2 and 9 in rabbits with doxorubicin-induced cardiomyopathy

ABSTRACT: Some studies have shown the role played by matrix metalloproteinases and their inhibitors in doxorubicin cardiotoxicity. In this study, we sought to investigate how plasma and myocardial MMP 2 and 9 perform in rabbits with doxorubicin-induced cardiomyopathy, searching for a correlation between the activity of these collagenases and cardiac remodeling. Cardiomyopathy was induced by doxorubicin given intravenously twice a week for six consecutive weeks. Plasma MMP activity and the echocardiogram were assessed at baseline, and at 15 and 45 days after first injection of doxorubicin. The myocardial activity of these enzymes was solely evaluated in nine rabbits at 45 days, and results were compared with nine healthy controls. We only identified the full-length forms of both MMP 2 and 9 throughout the study. The plasma pro-MMP 2 reduced along the deterioration of cardiac function, while the pro-MMP 9 increased significantly at T45 as compared to baseline and T15. A negative significant correlation was found to exist between the plasma activity of pro-MMP 2 and mitral E-to-mitral septal annular early diastolic velocity ratio, which is an estimate of mean left atrial pressure and congestion. Only pro-MMP 2 was found in myocardial samples, and mean activity of such enzyme was statistically lower than that recorded for healthy controls. Although no active form was documented for either collagenase, the duration of the treatment with doxorubicin played a role in the alteration of plasma pro-forms activity. However, these changes could not be associated with most echocardiographic parameters that are supportive of cardiac remodeling.

Saved in:
Bibliographic Details
Main Authors: Nogueira,Sheila S.S., Sousa,Marlos G., Gava,Fabio N., Rosa,Fernando A., Melo,Guilherme D., Dittrich,Gustavo, Machado,Gisele F., Camacho,Aparecido A.
Format: Digital revista
Language:English
Published: Colégio Brasileiro de Patologia Animal - CBPA 2018
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-736X2018000200320
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-736X2018000200320
record_format ojs
spelling oai:scielo:S0100-736X20180002003202018-04-19Matrix metalloproteinases 2 and 9 in rabbits with doxorubicin-induced cardiomyopathyNogueira,Sheila S.S.Sousa,Marlos G.Gava,Fabio N.Rosa,Fernando A.Melo,Guilherme D.Dittrich,GustavoMachado,Gisele F.Camacho,Aparecido A. Matrix metalloproteinases rabbits doxorubicin cardiomyopathy zymography enzyme activity cardiac disease echocardiogram collagenase clinics ABSTRACT: Some studies have shown the role played by matrix metalloproteinases and their inhibitors in doxorubicin cardiotoxicity. In this study, we sought to investigate how plasma and myocardial MMP 2 and 9 perform in rabbits with doxorubicin-induced cardiomyopathy, searching for a correlation between the activity of these collagenases and cardiac remodeling. Cardiomyopathy was induced by doxorubicin given intravenously twice a week for six consecutive weeks. Plasma MMP activity and the echocardiogram were assessed at baseline, and at 15 and 45 days after first injection of doxorubicin. The myocardial activity of these enzymes was solely evaluated in nine rabbits at 45 days, and results were compared with nine healthy controls. We only identified the full-length forms of both MMP 2 and 9 throughout the study. The plasma pro-MMP 2 reduced along the deterioration of cardiac function, while the pro-MMP 9 increased significantly at T45 as compared to baseline and T15. A negative significant correlation was found to exist between the plasma activity of pro-MMP 2 and mitral E-to-mitral septal annular early diastolic velocity ratio, which is an estimate of mean left atrial pressure and congestion. Only pro-MMP 2 was found in myocardial samples, and mean activity of such enzyme was statistically lower than that recorded for healthy controls. Although no active form was documented for either collagenase, the duration of the treatment with doxorubicin played a role in the alteration of plasma pro-forms activity. However, these changes could not be associated with most echocardiographic parameters that are supportive of cardiac remodeling.info:eu-repo/semantics/openAccessColégio Brasileiro de Patologia Animal - CBPAPesquisa Veterinária Brasileira v.38 n.2 20182018-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-736X2018000200320en10.1590/1678-5150-pvb-4990
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Nogueira,Sheila S.S.
Sousa,Marlos G.
Gava,Fabio N.
Rosa,Fernando A.
Melo,Guilherme D.
Dittrich,Gustavo
Machado,Gisele F.
Camacho,Aparecido A.
spellingShingle Nogueira,Sheila S.S.
Sousa,Marlos G.
Gava,Fabio N.
Rosa,Fernando A.
Melo,Guilherme D.
Dittrich,Gustavo
Machado,Gisele F.
Camacho,Aparecido A.
Matrix metalloproteinases 2 and 9 in rabbits with doxorubicin-induced cardiomyopathy
author_facet Nogueira,Sheila S.S.
Sousa,Marlos G.
Gava,Fabio N.
Rosa,Fernando A.
Melo,Guilherme D.
Dittrich,Gustavo
Machado,Gisele F.
Camacho,Aparecido A.
author_sort Nogueira,Sheila S.S.
title Matrix metalloproteinases 2 and 9 in rabbits with doxorubicin-induced cardiomyopathy
title_short Matrix metalloproteinases 2 and 9 in rabbits with doxorubicin-induced cardiomyopathy
title_full Matrix metalloproteinases 2 and 9 in rabbits with doxorubicin-induced cardiomyopathy
title_fullStr Matrix metalloproteinases 2 and 9 in rabbits with doxorubicin-induced cardiomyopathy
title_full_unstemmed Matrix metalloproteinases 2 and 9 in rabbits with doxorubicin-induced cardiomyopathy
title_sort matrix metalloproteinases 2 and 9 in rabbits with doxorubicin-induced cardiomyopathy
description ABSTRACT: Some studies have shown the role played by matrix metalloproteinases and their inhibitors in doxorubicin cardiotoxicity. In this study, we sought to investigate how plasma and myocardial MMP 2 and 9 perform in rabbits with doxorubicin-induced cardiomyopathy, searching for a correlation between the activity of these collagenases and cardiac remodeling. Cardiomyopathy was induced by doxorubicin given intravenously twice a week for six consecutive weeks. Plasma MMP activity and the echocardiogram were assessed at baseline, and at 15 and 45 days after first injection of doxorubicin. The myocardial activity of these enzymes was solely evaluated in nine rabbits at 45 days, and results were compared with nine healthy controls. We only identified the full-length forms of both MMP 2 and 9 throughout the study. The plasma pro-MMP 2 reduced along the deterioration of cardiac function, while the pro-MMP 9 increased significantly at T45 as compared to baseline and T15. A negative significant correlation was found to exist between the plasma activity of pro-MMP 2 and mitral E-to-mitral septal annular early diastolic velocity ratio, which is an estimate of mean left atrial pressure and congestion. Only pro-MMP 2 was found in myocardial samples, and mean activity of such enzyme was statistically lower than that recorded for healthy controls. Although no active form was documented for either collagenase, the duration of the treatment with doxorubicin played a role in the alteration of plasma pro-forms activity. However, these changes could not be associated with most echocardiographic parameters that are supportive of cardiac remodeling.
publisher Colégio Brasileiro de Patologia Animal - CBPA
publishDate 2018
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-736X2018000200320
work_keys_str_mv AT nogueirasheilass matrixmetalloproteinases2and9inrabbitswithdoxorubicininducedcardiomyopathy
AT sousamarlosg matrixmetalloproteinases2and9inrabbitswithdoxorubicininducedcardiomyopathy
AT gavafabion matrixmetalloproteinases2and9inrabbitswithdoxorubicininducedcardiomyopathy
AT rosafernandoa matrixmetalloproteinases2and9inrabbitswithdoxorubicininducedcardiomyopathy
AT meloguilhermed matrixmetalloproteinases2and9inrabbitswithdoxorubicininducedcardiomyopathy
AT dittrichgustavo matrixmetalloproteinases2and9inrabbitswithdoxorubicininducedcardiomyopathy
AT machadogiselef matrixmetalloproteinases2and9inrabbitswithdoxorubicininducedcardiomyopathy
AT camachoaparecidoa matrixmetalloproteinases2and9inrabbitswithdoxorubicininducedcardiomyopathy
_version_ 1756390210275377152